LIAS and cystic fibrosis: Taken together, the above results provide evidence that the ability of niclosamide and clofoctol to inhibit the production of QS signal molecules and QS-controlled virulence factors is highly variable and strain-dependent, and suggest that anti-pqs drugs might be more effective as antivirulence agents than anti-las drugs in CF therapy.